Strong first full quarter of AVLAYAH™ (tividenofusp alfa-eknm) launch generated $3.6 million in net product revenueAdvanced TransportVehicle™ portfolio with two Alzheimer’s disease programs now in ...

Terry Crews shared an emotional message about cherishing life as he posed with his wife, Rebecca King-Crews, amid her battle ...

A new study presents the first complete T2T marmoset genome, advancing Alzheimer's research and primate genomics.

BioVie’s stock fell by nearly 50% as the biotech claimed victory in a mid-stage Parkinson’s disease trial using an alternative endpoint to the one submitted to the FDA. BioVie declared that the ...

In this week's episode of "Live Well, Age Well", we're going over early warning signs of Parkinson's Disease, and debunking ...

In preclinical models of tauopathy experimental treatment rescued behavioral deficits, reduced neuroinflammation, and ...

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) said its drug candidate bezisterim met the prespecified endpoints of a Phase 2 trial ...

Patients treated with bezisterim demonstrated statistically significant improvements compared to placebo on both motor and non-motor symptoms, as assessed by MDS-UPDRS1 Parts I, II, and III, as well ...

BioVie has hailed phase 2 data as evidence that bezisterim could represent a “meaningful advance” in the treatment of ...